Christopher Sarchi's most recent trade in Replimune Group Inc was a trade of 12,000 Common Stock done at an average price of $9.2 . Disclosure was reported to the exchange on June 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 01 Jun 2026 | 12,000 | 180,962 (0%) | 0% | 9.2 | 110,880 | Common Stock |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 18 May 2026 | 8,626 | 192,962 (0%) | 0% | 5.1 | 43,820 | Common Stock |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 02 Apr 2026 | 6,500 | 151,588 (0%) | 0% | 8.0 | 52,065 | Common Stock |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 50,000 | 201,588 (0%) | 0% | 0 | Common Stock | |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 35,000 | 158,088 (0%) | 0% | 0 | Common Stock | |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.10 per share. | 17 Nov 2025 | 5,208 | 123,088 (0%) | 0% | 9.1 | 47,393 | Common Stock |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 20 May 2025 | 3,749 | 128,296 (0%) | 0% | 8.0 | 30,179 | Common Stock |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 67,500 | 67,500 | - | - | Employee Stock Option (right to buy) | |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 45,000 | 132,045 (0%) | 0% | 0 | Common Stock | |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.78 per share. | 18 Nov 2024 | 5,207 | 87,045 (0%) | 0% | 10.8 | 56,131 | Common Stock |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 16 May 2024 | 2,218 | 92,252 (0%) | 0% | 6.5 | 14,350 | Common Stock |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 66,675 | 66,675 | - | - | Employee Stock Option (right to buy) | |
| Replimune Grp Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 22,225 | 94,470 (0%) | 0% | 0 | Common Stock |